131 related articles for article (PubMed ID: 30366000)
1. Bradykinin B1 receptor contributes to interleukin-8 production and glioblastoma migration through interaction of STAT3 and SP-1.
Liu YS; Hsu JW; Lin HY; Lai SW; Huang BR; Tsai CF; Lu DY
Neuropharmacology; 2019 Jan; 144():143-154. PubMed ID: 30366000
[TBL] [Abstract][Full Text] [Related]
2. Bradykinin stimulates IL-6 production and cell invasion in colorectal cancer cells.
Wang G; Ye Y; Zhang X; Song J
Oncol Rep; 2014 Oct; 32(4):1709-14. PubMed ID: 25109623
[TBL] [Abstract][Full Text] [Related]
3. Glioblastoma-mesenchymal stem cell communication modulates expression patterns of kinin receptors: Possible involvement of bradykinin in information flow.
Pillat MM; Oliveira MN; Motaln H; Breznik B; Glaser T; Lah TT; Ulrich H
Cytometry A; 2016 Apr; 89(4):365-75. PubMed ID: 26671187
[TBL] [Abstract][Full Text] [Related]
4. STAT3 NH2-terminal acetylation is activated by the hepatic acute-phase response and required for IL-6 induction of angiotensinogen.
Ray S; Boldogh I; Brasier AR
Gastroenterology; 2005 Nov; 129(5):1616-32. PubMed ID: 16285960
[TBL] [Abstract][Full Text] [Related]
5. Primary Role for Kinin B
Nicoletti NF; Sénécal J; da Silva VD; Roxo MR; Ferreira NP; de Morais RLT; Pesquero JB; Campos MM; Couture R; Morrone FB
Mol Neurobiol; 2017 Dec; 54(10):7869-7882. PubMed ID: 27848207
[TBL] [Abstract][Full Text] [Related]
6. Bradykinin-induced cell migration and COX-2 production mediated by the bradykinin B1 receptor in glioma cells.
Lu DY; Leung YM; Huang SM; Wong KL
J Cell Biochem; 2010 May; 110(1):141-50. PubMed ID: 20411591
[TBL] [Abstract][Full Text] [Related]
7. Bradykinin promotes proliferation, migration, and invasion of cervical cancer cells through STAT3 signaling pathways.
Wang W; Zhou Y; Wei R; Jiang G; Li F; Chen X; Wang X; Ma D; Xi L
Oncol Rep; 2019 Dec; 42(6):2521-2527. PubMed ID: 31638249
[TBL] [Abstract][Full Text] [Related]
8. Neurotensin signaling regulates stem-like traits of glioblastoma stem cells through activation of IL-8/CXCR1/STAT3 pathway.
Zhou J; Yi L; Ouyang Q; Xu L; Cui H; Xu M
Cell Signal; 2014 Dec; 26(12):2896-902. PubMed ID: 25200966
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1.
Loeffler S; Fayard B; Weis J; Weissenberger J
Int J Cancer; 2005 Jun; 115(2):202-13. PubMed ID: 15688401
[TBL] [Abstract][Full Text] [Related]
10. Nuclear unphosphorylated STAT3 correlates with a worse prognosis in human glioblastoma.
Rodrigues BR; Queiroz-Hazarbassanov N; Lopes MH; Bleggi-Torres LF; Suzuki S; Cunha IW; Sanematsu P; Martins VR
Pathol Res Pract; 2016 Jun; 212(6):517-23. PubMed ID: 27013058
[TBL] [Abstract][Full Text] [Related]
11. Autoregulation of bradykinin receptors: agonists in the presence of interleukin-1beta shift the repertoire of receptor subtypes from B2 to B1 in human lung fibroblasts.
Phagoo SB; Poole S; Leeb-Lundberg LM
Mol Pharmacol; 1999 Aug; 56(2):325-33. PubMed ID: 10419551
[TBL] [Abstract][Full Text] [Related]
12. Both B1R and B2R act as intermediate signaling molecules in high glucose-induced stimulation of glutamate uptake in ARPE cells.
Lim SK; Han HJ; Kim KY; Park SH
J Cell Physiol; 2009 Dec; 221(3):677-87. PubMed ID: 19725054
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human and rabbit arterial smooth muscle cell migration mediated by the kinin B1 receptor: role of receptor density and released mediators.
Morissette G; Sabourin T; Adam A; Marceau F
Can J Physiol Pharmacol; 2006 Nov; 84(11):1107-19. PubMed ID: 17218975
[TBL] [Abstract][Full Text] [Related]
14. Quercetin abrogates IL-6/STAT3 signaling and inhibits glioblastoma cell line growth and migration.
Michaud-Levesque J; Bousquet-Gagnon N; Béliveau R
Exp Cell Res; 2012 May; 318(8):925-35. PubMed ID: 22394507
[TBL] [Abstract][Full Text] [Related]
15. Blockade of bradykinin receptor B1 but not bradykinin receptor B2 provides protection from cerebral infarction and brain edema.
Austinat M; Braeuninger S; Pesquero JB; Brede M; Bader M; Stoll G; Renné T; Kleinschnitz C
Stroke; 2009 Jan; 40(1):285-93. PubMed ID: 18988906
[TBL] [Abstract][Full Text] [Related]
16. [Study on the expression of bradykinin and its receptors B1R and B2R in the kidney immune injury in trichloroethylene-sensitized mouse].
Wang H; Zhang J; Li S; Zha W; Wang F; Zhu Q
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2015 Jul; 33(7):486-91. PubMed ID: 26653642
[TBL] [Abstract][Full Text] [Related]
17. CFTR activation suppresses glioblastoma cell proliferation, migration and invasion.
Zhong X; Chen HQ; Yang XL; Wang Q; Chen W; Li C
Biochem Biophys Res Commun; 2019 Jan; 508(4):1279-1285. PubMed ID: 30573361
[TBL] [Abstract][Full Text] [Related]
18. Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation.
Leidgens V; Proske J; Rauer L; Moeckel S; Renner K; Bogdahn U; Riemenschneider MJ; Proescholdt M; Vollmann-Zwerenz A; Hau P; Seliger C
Oncotarget; 2017 Jan; 8(5):8250-8263. PubMed ID: 28030813
[TBL] [Abstract][Full Text] [Related]
19. The kallikrein-Kinin system modulates the progression of colorectal liver metastases in a mouse model.
da Costa PLN; Wynne D; Fifis T; Nguyen L; Perini M; Christophi C
BMC Cancer; 2018 Apr; 18(1):382. PubMed ID: 29618333
[TBL] [Abstract][Full Text] [Related]
20. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
